Building upon partnerships with thought leading clinicians worldwide, TriVascular develops products designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/04/12 | $60,000,000 | Series D |
Delphi Ventures Kaiser Permanente Ventures Kearny Venture Partners MPM Capital Pinnacle Ventures | undisclosed |
| 11/18/13 | $40,000,000 | Series E |
Deerfield Management Company, L.P. Delphi Ventures Kaiser Permanente Ventures Kearny Venture Partners MPM Capital Redmile Group Rock Springs Capital | undisclosed |
